Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Zedira |
Description | Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and |
Keywords | N/A |
WebSite | zedira.com |
Host IP | 188.40.158.113 |
Location | Germany |
Site | Rank |
US$6,090,305
Last updated: 2023-05-07 03:40:44
zedira.com has Semrush global rank of 1,737,894. zedira.com has an estimated worth of US$ 6,090,305, based on its estimated Ads revenue. zedira.com receives approximately 702,728 unique visitors each day. Its web server is located in Germany, with IP address 188.40.158.113. According to SiteAdvisor, zedira.com is safe to visit. |
Purchase/Sale Value | US$6,090,305 |
Daily Ads Revenue | US$5,622 |
Monthly Ads Revenue | US$168,655 |
Yearly Ads Revenue | US$2,023,855 |
Daily Unique Visitors | 46,849 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
zedira.com. | A | 3599 | IP: 188.40.158.113 |
zedira.com. | NS | 3600 | NS Record: ns4.sturmlan.net. |
zedira.com. | NS | 3600 | NS Record: ns3.sturmlan.net. |
zedira.com. | NS | 3600 | NS Record: ns2.sturmlan.net. |
zedira.com. | MX | 3600 | MX Record: 10 minas-tirith.sturmlan.net. |
zedira.com. | TXT | 3600 | TXT Record: v=spf1 a mx a:minas-tirith.sturmlan.net a:mail-minas-tirith.sturmlan.net a:mail.minas-tirith.sturmlan.net a:mail2-minas-tirith.sturmlan.net a:mail2.minas-tirith.sturmlan.net a:mail3-minas-tirith.sturmlan.net a:mail3.minas-tirith.sturmlan.net include:spf.c rsend.com ~all |
zedira.com. | TXT | 3600 | TXT Record: Generated by Sturm Hostmaster |
zedira.com. | TXT | 3600 | TXT Record: google-site-verification=9fsA06ZFAlr4OEc5q5TA4FiUM2fe1ZGzRs5rPazYPzg |
ISO 9001 | Stay informed and subscribe our newsletter Our newsletter Cart (0) Home Company Products Services Medicine Business Development Andracon™ - recombinant microbial transglutaminase Your reliable tool for site-specific ADC-production and beyond! Read more Zöliakie-Studienteilnehmer gesucht! Für eine Wirksamkeitsstudie mit dem Studienmedikament ZED1227 (Link zu dzg-online.de) Read more Start of phase 2a proof of concept study of ZED1227 for the treatment of non-alcoholic fatty liver disease (NAFLD) Read more Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy Read more Reversibly acting TG2 inhibitors Drug candidates for the treatment of fibrosis Read more Previous Next News Link Wir suchen: Biologielaborant*in, BTA, MTA (m/w/d) im Bereich Proteinproduktion in Vollzeit Link Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Wed, 27 Oct 2021 06:25:30 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive X-Powered-By: PHP/5.5.38 Location: https://zedira.com/ HTTP/2 200 server: nginx date: Wed, 27 Oct 2021 06:25:31 GMT content-type: text/html; charset=utf-8 x-powered-by: PHP/5.5.38 |
Domain Name: ZEDIRA.COM Registry Domain ID: 1017222328_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.psi-usa.info Registrar URL: http://www.psi-usa.info Updated Date: 2021-06-09T07:21:15Z Creation Date: 2007-06-08T16:41:59Z Registry Expiry Date: 2022-06-08T16:41:59Z Registrar: PSI-USA, Inc. dba Domain Robot Registrar IANA ID: 151 Registrar Abuse Contact Email: domain-abuse@psi-usa.info Registrar Abuse Contact Phone: +49.94159559482 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS2.STURMLAN.NET Name Server: NS3.STURMLAN.NET Name Server: NS4.STURMLAN.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T04:06:06Z <<< |